K Hou-Jensen

4.3k total citations
87 papers, 3.4k citations indexed

About

K Hou-Jensen is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, K Hou-Jensen has authored 87 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 24 papers in Pathology and Forensic Medicine and 19 papers in Molecular Biology. Recurrent topics in K Hou-Jensen's work include Lymphoma Diagnosis and Treatment (18 papers), Cutaneous Melanoma Detection and Management (16 papers) and Chronic Lymphocytic Leukemia Research (14 papers). K Hou-Jensen is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Cutaneous Melanoma Detection and Management (16 papers) and Chronic Lymphocytic Leukemia Research (14 papers). K Hou-Jensen collaborates with scholars based in Denmark, United Kingdom and United States. K Hou-Jensen's co-authors include Elisabeth Ralfkiær, Maxwell Sehested, Jesper Zeuthen, Per Guldberg, Anne Østerlind, Vibeke Ahrenkiel, Kirsten Grønbæk, Ole Møller Jensen, J Pedersen-Bjergaard and Preben Philip and has published in prestigious journals such as New England Journal of Medicine, Blood and Cancer.

In The Last Decade

K Hou-Jensen

84 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Hou-Jensen Denmark 32 1.4k 927 873 683 665 87 3.4k
Harald Stein Germany 19 1.2k 0.9× 1.1k 1.2× 1.1k 1.3× 317 0.5× 1.1k 1.6× 20 4.1k
Harald Stein Germany 33 1.5k 1.1× 941 1.0× 1.9k 2.1× 467 0.7× 1.1k 1.7× 53 4.0k
Leonardo Flenghi Italy 24 876 0.6× 536 0.6× 1.5k 1.7× 346 0.5× 975 1.5× 36 2.7k
R Warnke United States 24 1.3k 1.0× 718 0.8× 1.6k 1.8× 475 0.7× 1.7k 2.5× 32 4.1k
C. De Wolf‐Peeters Belgium 28 821 0.6× 373 0.4× 1.0k 1.2× 242 0.4× 595 0.9× 78 2.8k
Bertram Schnitzer United States 32 988 0.7× 380 0.4× 1.6k 1.8× 288 0.4× 625 0.9× 142 3.1k
TM Grogan United States 26 2.0k 1.5× 1.0k 1.1× 1.4k 1.6× 212 0.3× 603 0.9× 58 3.6k
H. Stein Germany 29 817 0.6× 511 0.6× 1.1k 1.3× 256 0.4× 861 1.3× 63 2.8k
J P Sloane United Kingdom 22 706 0.5× 374 0.4× 730 0.8× 300 0.4× 388 0.6× 34 1.9k
Stefano Ascani Italy 32 1.6k 1.2× 761 0.8× 2.1k 2.4× 484 0.7× 757 1.1× 181 4.0k

Countries citing papers authored by K Hou-Jensen

Since Specialization
Citations

This map shows the geographic impact of K Hou-Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Hou-Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Hou-Jensen more than expected).

Fields of papers citing papers by K Hou-Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Hou-Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Hou-Jensen. The network helps show where K Hou-Jensen may publish in the future.

Co-authorship network of co-authors of K Hou-Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of K Hou-Jensen. A scholar is included among the top collaborators of K Hou-Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Hou-Jensen. K Hou-Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lauritzen, Anne F., Gunhild L. Vejlsgaard, K Hou-Jensen, & Elisabeth Ralfkiær. (2006). p53 protein expression in cutaneous T-cell lymphomas. British Journal of Dermatology. 133(1). 32–36. 4 indexed citations
3.
Grønbæk, Kirsten, Trine Nedergaard, Kim Thomsen, et al.. (2000). Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases. British Journal of Dermatology. 142(5). 913–923. 61 indexed citations
5.
Haerslev, T, et al.. (1997). Bcl‐2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas. Apmis. 105(1-6). 35–40. 10 indexed citations
7.
Lock‐Andersen, Jørgen, et al.. (1995). Observer Variation in Histological Classification of Cutaneous Malignant Melanoma. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 29(2). 141–148. 39 indexed citations
8.
Straten, Per thor, et al.. (1994). Preferential usage of T‐cell receptor αβ variable regions among tumor‐infiltrating lymphocytes in primary human malignant melanomas. International Journal of Cancer. 56(1). 78–86. 28 indexed citations
9.
Lauritzen, Anne F., et al.. (1994). Histiocytic Sarcomas and Monoblastic Leukemias:A Clinical, Histologic, and Immunophenotypical Study. American Journal of Clinical Pathology. 102(1). 45–54. 50 indexed citations
10.
Lauritzen, Anne F., K Hou-Jensen, & Elisabeth Ralfkiær. (1993). P53 protein expression in Hodgkin's disease. Apmis. 101(7-12). 689–694. 11 indexed citations
12.
Hastrup, Nina, et al.. (1991). The Presence of Dysplastic Nevus Remnants in Malignant Melanomas. American Journal of Dermatopathology. 13(4). 378–385. 31 indexed citations
13.
Laurberg, Grete, N Hjorth, Per Sonne Holm, et al.. (1991). Treatment of lichen planus with acitretin. Journal of the American Academy of Dermatology. 24(3). 434–437. 109 indexed citations
14.
Schultz, Henrik B., Jens Ersbøll, Nis I. Nissen, & K Hou-Jensen. (1989). A simplified working formulation of non-Hodgkin's lymphomas based on quantifiable histologic criteria. Cancer. 64(12). 2532–2540. 3 indexed citations
15.
Daugaard, Søren, et al.. (1988). Malignant haemangiopericytomas and haemangioendotheliosarcomas: an immunohistochemical study. Histopathology. 12(4). 405–414. 28 indexed citations
16.
Vlatkovic, Ljiljana, Anne E. Lykkesfeldt, K Hou-Jensen, & Per Briand. (1987). Comparison of the immunocytochemical assay (ER-ICA) and the biochemical assay for estrogen receptor in human breast cancer cell lines. European Journal of Cancer and Clinical Oncology. 23(6). 755–760. 6 indexed citations
17.
Gatter, K C, Elisabeth Ralfkiær, D C Brown, et al.. (1985). An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.. Journal of Clinical Pathology. 38(12). 1353–1357. 96 indexed citations
18.
Hou-Jensen, K, et al.. (1984). Lymphomatoid papulosis: a follow-up study. Acta Dermato Venereologica. 64(1). 46–51. 10 indexed citations
19.
Stahl, Dorrit, et al.. (1979). Kveim test in sarcoidosis. A report of a Danish Kveim material.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(1). 6–9. 3 indexed citations
20.
Schultz, Henrik B. & K Hou-Jensen. (1975). [Immunoblast lymphadenopathy (ILA): a new syndrome on the borderline between reactive and maglignant lymphoma].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 138(1). 20–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026